Repligen Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Repligen Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $690 of operating cash. Higher than almost all Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$690Over the last 3 years, every $100 of reported profit came with $690 of operating cash.
Higher than almost all Healthcare companies in United States.
Self-Funding Ratio
4.2×Over the last 3 years its own operating cash covered its investment spending (capex) 4.2 times.
Higher than 84% of Healthcare companies in United States.
Cash Locked Ratio
$40For every $100 of sales, $40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $40 tied up three years earlier.
More money tied up than 81% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 8%
Sales fell 8% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-8% / +17%In 3 years sales changed by -8% while total assets changed by +17%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
5.4×Debt due within a year is covered 5.4 times by its yearly operating cash.
Higher than 81% of Healthcare companies in United States.
Cash Cushion Ratio
+1%Cash, after subtracting all debt, equals 1% of its market value (net cash).
Lower than 66% of Healthcare companies in United States.
Tangible Assets Ratio
49%Of every $100 the company owns, $49 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 81% of Healthcare companies in United States.
Tangible Net Worth Ratio
29%Of every $100 of net worth, $29 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 61% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Repligen Corporation owes $0.28 for every $1 it owns. Repligen Corporation returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
244.8Investors pay $244.8 for every $1 of Repligen Corporation's yearly profit, higher than 97% of Healthcare companies in United States.
P/B ratio
5.37The share price is 5.37 times Repligen Corporation's book value per share, higher than 74% of Healthcare companies in United States.
Market cap
$11.3 BThe total market value of all of Repligen Corporation's shares at today's price (share price × number of shares), larger than 91% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$2.1 BWhat Repligen Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$33.27Net worth divided by the number of shares. The share price of $178.71 is 5.4 times this, which is the P/B above.
Return on equity (ROE)
2.0%Repligen Corporation earned 2.0% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.
Owes vs Owns
0.28×Repligen Corporation owes $0.28 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.
Dividend yield
NoneRepligen Corporation does not currently pay a dividend.
Revenue growth
+16%Revenue rose 16% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Profit growth
Back to profitRepligen Corporation returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
6.6%Repligen Corporation keeps $7 of every $100 of revenue as net profit.
Cash quality
2.4×Cash from Repligen Corporation's business was 2.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
1.9×Repligen Corporation's operating profit covered its interest costs 1.9 times in the year to Dec 2025.
Cash vs debt
Net cashRepligen Corporation held $78 M more cash than debt (net cash) at Dec 2025.
Questions
What is Repligen Corporation's P/E ratio?
Investors pay $244.8 for every $1 of Repligen Corporation's yearly profit, higher than 97% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Repligen Corporation: $11.3 B ÷ $2.1 B (30 Jun 2026) = 5.4.
What is Repligen Corporation's return on equity?
Repligen Corporation earned 2.0% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.
How much does Repligen Corporation owe compared with what it owns?
Repligen Corporation owes $0.28 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.
Does Repligen Corporation pay a dividend?
No. Repligen Corporation does not currently pay a dividend.
Is Repligen Corporation's revenue growing?
Revenue rose 16% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.